Omega Fund Vi Gp, L.p. - Net Worth and Insider Trading
Omega Fund Vi Gp, L.p. Net Worth
The estimated net worth of Omega Fund Vi Gp, L.p. is at least $29 Million dollars as of 2024-05-10. Omega Fund Vi Gp, L.p. is the 10% Owner of Lexeo Therapeutics Inc and owns about 2,157,623 shares of Lexeo Therapeutics Inc (LXEO) stock worth over $29 Million. Details can be seen in Omega Fund Vi Gp, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Omega Fund Vi Gp, L.p. has not made any transactions after 2023-11-07 and currently still holds the listed stock(s).
Transaction Summary of Omega Fund Vi Gp, L.p.
Omega Fund Vi Gp, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Omega Fund Vi Gp, L.p. owns 5 companies in total, including Spruce Biosciences Inc (SPRB) , Imago BioSciences Inc (IMGO) , and Theseus Pharmaceuticals Inc (THRX) among others .
Click here to see the complete history of Omega Fund Vi Gp, L.p.’s form 4 insider trades.
Insider Ownership Summary of Omega Fund Vi Gp, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SPRB | Spruce Biosciences Inc | 2020-10-08 | 10 percent owner |
| IMGO | Imago BioSciences Inc | 2021-07-15 | 10 percent owner |
| THRX | Theseus Pharmaceuticals Inc | 2021-10-06 | 10 percent owner |
 | | 2021-01-06 | 10 percent owner |
| | 2023-11-07 | 10 percent owner |
Omega Fund Vi Gp, L.p. Latest Holdings Summary
Omega Fund Vi Gp, L.p. currently owns a total of 1 stock. Omega Fund Vi Gp, L.p. owns 2,157,623 shares of Lexeo Therapeutics Inc (LXEO) as of November 7, 2023, with a value of $29 Million.
Latest Holdings of Omega Fund Vi Gp, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics Inc | 2023-11-07 | 2,157,623 | 13.33 | 28,750,326 |
Holding Weightings of Omega Fund Vi Gp, L.p.
Omega Fund Vi Gp, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Omega Fund Vi Gp, L.p. has made a total of 1 transactions in Lexeo Therapeutics Inc (LXEO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lexeo Therapeutics Inc is the acquisition of 454,545 shares on November 7, 2023, which cost Omega Fund Vi Gp, L.p. around $5 Million.
Insider Trading History of Omega Fund Vi Gp, L.p.
- 1
Omega Fund Vi Gp, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Omega Fund Vi Gp, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Omega Fund Vi Gp, L.p. is 62.52%. GuruFocus also compares Omega Fund Vi Gp, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Omega Fund Vi Gp, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Omega Fund Vi Gp, L.p.'s insider trading performs compared to the benchmark.
Performance of Omega Fund Vi Gp, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 24.28 | | | | | |
| Relative Return to S&P 500(%) | 19.55 | | | | | |
Omega Fund Vi Gp, L.p. Ownership Network
Omega Fund Vi Gp, L.p. Owned Company Details
What does Spruce Biosciences Inc do?
Who are the key executives at Spruce Biosciences Inc?
Omega Fund Vi Gp, L.p. is the 10 percent owner of Spruce Biosciences Inc. Other key executives at Spruce Biosciences Inc include 10 percent owner Novo Holdings A/s , Chief Medical Officer Charlton Ralph William Iii , and director & Chief Executive Officer Javier B. Szwarcberg .
Spruce Biosciences Inc (SPRB) Insider Trades Summary
Over the past 18 months, Omega Fund Vi Gp, L.p. made no insider transaction in Spruce Biosciences Inc (SPRB). Other recent insider transactions involving Spruce Biosciences Inc (SPRB) include a net sale of 1,964,336 shares made by Novo Holdings A/s , and a net purchase of 630,400 shares made by Niall O'donnell .
In summary, during the past 3 months, insiders sold 4,172,336 shares of Spruce Biosciences Inc (SPRB) in total and bought 0 shares, with a net sale of 4,172,336 shares. During the past 18 months, 4,172,336 shares of Spruce Biosciences Inc (SPRB) were sold and 2,838,400 shares were bought by its insiders, resulting in a net sale of 1,333,936 shares.
Spruce Biosciences Inc (SPRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spruce Biosciences Inc Insider Transactions
Omega Fund Vi Gp, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Omega Fund Vi Gp, L.p.. You might contact Omega Fund Vi Gp, L.p. via mailing address: 888 Boylston Street, Suite 1111, Boston Ma 02199.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
